Enlivex Therapeutics (ENLV) Earnings Date, Estimates & Call Transcripts $0.96 +0.03 (+2.75%) Closing price 05/30/2025 03:59 PM EasternExtended Trading$0.94 -0.02 (-2.43%) As of 05/30/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enlivex Therapeutics Earnings Summary Enlivex Therapeutics released Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.23, which missed the consensus estimate of -$0.16 by $0.07. With a trailing EPS of -$0.73, Enlivex Therapeutics' earnings are expected to grow next year, from ($0.70) to ($0.58) per share. Upcoming Earnings DateJun. 13Before Market OpensEstimatedConsensus EPS (Mar. 31) -$0.16 Actual EPS (Mar. 31) -$0.23 Missed By -$0.07 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (20-F)ENLV Upcoming EarningsEnlivex Therapeutics' Q4 2024 earnings is scheduled for Friday, June 13, 2025Powered by Get Enlivex Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enlivex Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataENLV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Enlivex Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.16-$0.16-$0.16Q2 20251-$0.16-$0.16-$0.16Q3 20251-$0.14-$0.14-$0.14Q4 20251-$0.13-$0.13-$0.13 Enlivex Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/13/2025(Estimated)--------3/31/2025Q4 2024-$0.16-$0.23 -$0.07-$0.23--11/29/2024Q3 2024-$0.16-$0.12+$0.04-$0.12--8/30/2024Q2 2024-$0.22-$0.16+$0.06-$0.16--6/14/2024Q1 2024-$0.25-$0.22+$0.03-$0.22--3/29/2024Q4 2023--$0.48 -$0.48-$0.48--11/9/2023Q3 2023-$0.32-$0.32--$0.32--9/1/2023Q2 2023-$0.43-$0.37+$0.06-$0.37--6/26/2023Q1 2023-$0.40-$0.40----6/16/2023Q1 2023-$0.40-$0.39+$0.01-$0.39-- Enlivex Therapeutics Earnings - Frequently Asked Questions When is Enlivex Therapeutics's earnings date? Enlivex Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 13th, 2025 based off last year's report dates. Learn more on ENLV's earnings history. Did Enlivex Therapeutics beat their earnings estimates last quarter? In the previous quarter, Enlivex Therapeutics (NASDAQ:ENLV) missed the analysts' consensus estimate of ($0.16) by $0.07 with a reported earnings per share (EPS) of ($0.23). Learn more on analysts' earnings estimate vs. ENLV's actual earnings. How much profit does Enlivex Therapeutics generate each year? Enlivex Therapeutics (NASDAQ:ENLV) has a recorded net income of -$29.07 million. ENLV has generated -$0.73 earnings per share over the last four quarters. What is Enlivex Therapeutics's EPS forecast for next year? Enlivex Therapeutics's earnings are expected to grow from ($0.70) per share to ($0.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies Cardiol Therapeutics Earnings Results Corbus Pharmaceuticals Earnings Results Invivyd Earnings Results Cabaletta Bio Earnings Results Entera Bio Earnings Results Immunic Earnings Results Coherus BioSciences Earnings Results Oramed Pharmaceuticals Earnings Results XBiotech Earnings Results Zentalis Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles e.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the Stock This page (NASDAQ:ENLV) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enlivex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENLV Stock Free ENLV Stock Alerts